Abstract
Current monitoring of childhood asthma focuses on the level of asthma control and reduction of future risk to the patient. However, guidelines are not clear in their recommendations on the best strategy to monitor asthmatic children. As asthma is a heterogeneous disease with symptoms, airways obstruction, airways hyperresponsiveness and chronic inflammation as the principal components, no single outcome measure can be expected to adequately assess asthma control. To determine the level of control, standardized questionnaires like the asthma control test (ACT), asthma control questionnaire (ACQ) and asthma therapy assessment questionnaire (ATAQ) may be used. Whether the use of such questionnaires actually improves asthma control remains to be shown. Spirometry and measurement of reversibility are recommended at least once per year to assess control and future risk. There is no need for bronchoprovocation testing as a routine monitoring tool in childhood asthma, but airway hyperresponsiveness might be important in estimating future risk. The fraction of nitric oxide in exhaled air (FENO) reflects eosinophilic airway inflammation. Recent studies only showed modest effects on asthma outcomes as a result of FENO monitoring in children.
Keywords: Asthma control, symptoms, questionnaires, lung function, exhaled nitric oxide
Current Pediatric Reviews
Title: Measuring Control: How can Response to Asthma Treatment be Measured?
Volume: 6 Issue: 2
Author(s): Marielle W.H. Pijnenburg
Affiliation:
Keywords: Asthma control, symptoms, questionnaires, lung function, exhaled nitric oxide
Abstract: Current monitoring of childhood asthma focuses on the level of asthma control and reduction of future risk to the patient. However, guidelines are not clear in their recommendations on the best strategy to monitor asthmatic children. As asthma is a heterogeneous disease with symptoms, airways obstruction, airways hyperresponsiveness and chronic inflammation as the principal components, no single outcome measure can be expected to adequately assess asthma control. To determine the level of control, standardized questionnaires like the asthma control test (ACT), asthma control questionnaire (ACQ) and asthma therapy assessment questionnaire (ATAQ) may be used. Whether the use of such questionnaires actually improves asthma control remains to be shown. Spirometry and measurement of reversibility are recommended at least once per year to assess control and future risk. There is no need for bronchoprovocation testing as a routine monitoring tool in childhood asthma, but airway hyperresponsiveness might be important in estimating future risk. The fraction of nitric oxide in exhaled air (FENO) reflects eosinophilic airway inflammation. Recent studies only showed modest effects on asthma outcomes as a result of FENO monitoring in children.
Export Options
About this article
Cite this article as:
W.H. Pijnenburg Marielle, Measuring Control: How can Response to Asthma Treatment be Measured?, Current Pediatric Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339610791561114
DOI https://dx.doi.org/10.2174/157339610791561114 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Potential of Natural Products in Parkinson’s Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Climate Changes and Human Health: A Review of the Effect of Environmental Stressors on Cardiovascular Diseases Across Epidemiology and Biological Mechanisms
Current Pharmaceutical Design Anesthesia for Bronchoscopy
Current Pharmaceutical Design Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
Current Medicinal Chemistry The Role of Antihistamines in the Management of Allergic Rhinitis
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Development of New H1 Antihistamines: The Importance of Pharmacokinetics in the Evaluation of Safe and Therapeutically Effective Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Role of Breathing Exercises and Yoga/Pranayama in Childhood Asthma: A Systematic Review
Current Pediatric Reviews Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs
Current Drug Metabolism Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations
Current Medicinal Chemistry Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response
Recent Patents on CNS Drug Discovery (Discontinued) Properties and Therapeutic Potential of Transient Receptor Potential Channels with Putative Roles in Adversity: Focus on TRPC5, TRPM2 and TRPA1
Current Drug Targets A Focus on Pharmacological Management of Catecholaminergic Polymorphic Ventricular Tachycardia
Mini-Reviews in Medicinal Chemistry Melanin-Concentrating Hormone Receptor 1 Antagonists: A New Perspective for the Pharmacologic Treatment of Obesity
Current Medicinal Chemistry Endogenous Acetylcholine Controls the Severity of Polymicrobial Sepsisassociated Inflammatory Response in Mice
Current Neurovascular Research Receptor-Based 3D-QSAR Study for Recognizing True Binding Mode of Mercaptoacyldipeptides at the Active Site of Neutral Endopeptidase
Medicinal Chemistry Pain Perception and Management: Where do We Stand?
Current Molecular Pharmacology Dietary Assumption of Plant Polyphenols and Prevention of Allergy
Current Pharmaceutical Design Inhibitors of the Microsomal Prostaglandin E2 Synthase-1 as Alternative to Non Steroidal Anti-Inflammatory Drugs (NSAIDs) – A Critical Review
Current Medicinal Chemistry A2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists
Current Pharmaceutical Design Pneumococcal Infections at Hajj: Current Knowledge Gaps
Infectious Disorders - Drug Targets